These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 17704827)

  • 1. The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects.
    Johns DG; Behm DJ; Walker DJ; Ao Z; Shapland EM; Daniels DA; Riddick M; Dowell S; Staton PC; Green P; Shabon U; Bao W; Aiyar N; Yue TL; Brown AJ; Morrison AD; Douglas SA
    Br J Pharmacol; 2007 Nov; 152(5):825-31. PubMed ID: 17704827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.
    Thomas A; Baillie GL; Phillips AM; Razdan RK; Ross RA; Pertwee RG
    Br J Pharmacol; 2007 Mar; 150(5):613-23. PubMed ID: 17245363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The orphan receptor GPR55 is a novel cannabinoid receptor.
    Ryberg E; Larsson N; Sjögren S; Hjorth S; Hermansson NO; Leonova J; Elebring T; Nilsson K; Drmota T; Greasley PJ
    Br J Pharmacol; 2007 Dec; 152(7):1092-101. PubMed ID: 17876302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the putative cannabinoid receptor (GPR55)-mediated inhibitory effects on intestinal contractility in mice.
    Ross GR; Lichtman A; Dewey WL; Akbarali HI
    Pharmacology; 2012; 90(1-2):55-65. PubMed ID: 22759743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans.
    Liu B; Song S; Ruz-Maldonado I; Pingitore A; Huang GC; Baker D; Jones PM; Persaud SJ
    Diabetes Obes Metab; 2016 Dec; 18(12):1263-1273. PubMed ID: 27561953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPR55 and the vascular receptors for cannabinoids.
    Hiley CR; Kaup SS
    Br J Pharmacol; 2007 Nov; 152(5):559-61. PubMed ID: 17704825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
    Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice.
    Li K; Fichna J; Schicho R; Saur D; Bashashati M; Mackie K; Li Y; Zimmer A; Göke B; Sharkey KA; Storr M
    Neuropharmacology; 2013 Aug; 71(100):255-63. PubMed ID: 23603203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular pharmacology of a novel cannabinoid-like compound, 3-(5-dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1-methyl-ethyl)benzamide (VSN16) in the rat.
    Hoi PM; Visintin C; Okuyama M; Gardiner SM; Kaup SS; Bennett T; Baker D; Selwood DL; Hiley CR
    Br J Pharmacol; 2007 Nov; 152(5):751-64. PubMed ID: 17891160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment.
    Schicho R; Bashashati M; Bawa M; McHugh D; Saur D; Hu HM; Zimmer A; Lutz B; Mackie K; Bradshaw HB; McCafferty DM; Sharkey KA; Storr M
    Inflamm Bowel Dis; 2011 Aug; 17(8):1651-64. PubMed ID: 21744421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells.
    Chiurchiù V; Lanuti M; De Bardi M; Battistini L; Maccarrone M
    Int Immunol; 2015 Mar; 27(3):153-60. PubMed ID: 25344934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids inhibit noradrenergic and purinergic sympathetic cotransmission in the rat isolated mesenteric arterial bed.
    Pakdeechote P; Dunn WR; Ralevic V
    Br J Pharmacol; 2007 Nov; 152(5):725-33. PubMed ID: 17641668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid receptor and WIN 55 212-2-stimulated [35S]-GTPgammaS binding in the brain of mu-, delta- and kappa-opioid receptor knockout mice.
    Berrendero F; Mendizábal V; Murtra P; Kieffer BL; Maldonado R
    Eur J Neurosci; 2003 Oct; 18(8):2197-202. PubMed ID: 14622180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice.
    McKillop AM; Moran BM; Abdel-Wahab YH; Flatt PR
    Br J Pharmacol; 2013 Nov; 170(5):978-90. PubMed ID: 23992544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A GPR18-based signalling system regulates IOP in murine eye.
    Caldwell MD; Hu SS; Viswanathan S; Bradshaw H; Kelly ME; Straiker A
    Br J Pharmacol; 2013 Jun; 169(4):834-43. PubMed ID: 23461720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands.
    Kapur A; Zhao P; Sharir H; Bai Y; Caron MG; Barak LS; Abood ME
    J Biol Chem; 2009 Oct; 284(43):29817-27. PubMed ID: 19723626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressure.
    Szczesniak AM; Maor Y; Robertson H; Hung O; Kelly ME
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):427-35. PubMed ID: 21770780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans.
    Romero-Zerbo SY; Rafacho A; Díaz-Arteaga A; Suárez J; Quesada I; Imbernon M; Ross RA; Dieguez C; Rodríguez de Fonseca F; Nogueiras R; Nadal A; Bermúdez-Silva FJ
    J Endocrinol; 2011 Nov; 211(2):177-85. PubMed ID: 21885477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of vasorelaxation induced by the cannabidiol analogue compound O-1602 in the rat small mesenteric artery.
    Al Suleimani YM; Al Mahruqi AS; Hiley CR
    Eur J Pharmacol; 2015 Oct; 765():107-14. PubMed ID: 26297305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo.
    Pertwee RG; Thomas A; Stevenson LA; Ross RA; Varvel SA; Lichtman AH; Martin BR; Razdan RK
    Br J Pharmacol; 2007 Mar; 150(5):586-94. PubMed ID: 17245367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.